Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
An ocular insert is a sterile solid or semisolid dosage form placed in or near the eye to provide local treatment over time. Some inserts dissolve or erode, while others remain until removed or expelled. They can release an active drug, provide lubrication, or support another therapeutic purpose. An ocular insert differs from ordinary eye drops because it stays at the treatment site for an extended period.
read more about ocular insert ...Ocular inserts can be used for dry-eye symptoms, inflammation, pain after eye surgery, glaucoma treatment, or other product-specific conditions. Hydroxypropyl cellulose inserts provide prolonged lubrication for selected patients with dry eye. Dexamethasone intracanalicular inserts release corticosteroid after ophthalmic procedures. Intraocular implants are related sustained-delivery systems but are placed inside the eye and are not handled like conjunctival inserts.
Tear fluid can hydrate or dissolve an insert and release its contents gradually. Other products use biodegradable polymers, diffusion-controlled matrices, or channels that regulate drug movement. Prolonged contact can extend local exposure and reduce the need for frequent drops. Release rate depends on the material, drug properties, placement site, tear environment, and product design.
Placement depends on the product and can involve the conjunctival sac, tear drainage canal, or another ocular location. Some inserts are placed by the patient with an applicator after training, while others require an eye-care professional. Hands, applicators, and packaging must be handled according to sterile or clean-use instructions. The insert should not be moved, reused, or removed unless the product directions or clinician call for it.
Possible effects include foreign-body sensation, blurred vision, tearing, redness, irritation, swelling, or accidental displacement. Drug-releasing inserts can also cause the adverse effects associated with the active medicine, such as increased eye pressure with corticosteroids. Incorrect placement can scratch the ocular surface or reduce treatment effectiveness. Eye pain, marked redness, discharge, sudden vision change, or a missing insert requires prompt professional advice.
No. An eye drop is a liquid dose, while an insert remains in or near the eye and commonly releases material over a longer period.
Some conjunctival inserts are designed for trained patient placement. Intracanalicular or intraocular products require an eye-care professional.
Yes. Temporary blurred vision or foreign-body sensation can occur after placement. Persistent or severe changes require evaluation.
No. Some dissolve or biodegrade, while others remain intact and must be removed or can pass from the placement site.
Drug Products, Including Biological Products, That Contain Nanomaterials: Guidance for Industry. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/drug-products-including-biological-products-contain-nanomaterials-guidance-industry. Date Accessed August 6, 2026.
Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/liposome-drug-products-chemistry-manufacturing-and-controls-human-pharmacokinetics-and. Date Accessed August 6, 2026.
DOXIL (Doxorubicin Hydrochloride Liposome Injection): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1c153e9e-4cf2-4ac7-9cf9-16f9b48d7dce. Date Accessed August 6, 2026.
ABRAXANE (Paclitaxel Protein-Bound Particles for Injectable Suspension): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4. Date Accessed August 6, 2026.
ONPATTRO (Patisiran Lipid Complex Injection): Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e87ec36f-b4b4-49d4-aea4-d4ffb09b0970. Date Accessed August 6, 2026.